ID: ALA4212968

Max Phase: Preclinical

Molecular Formula: C32H54O4

Molecular Weight: 502.78

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](OCC(=O)O)C(C)(C)[C@@H]1CC3

Standard InChI:  InChI=1S/C32H54O4/c1-21(10-9-16-28(2,3)35)22-13-18-32(8)24-11-12-25-29(4,5)26(36-20-27(33)34)15-17-30(25,6)23(24)14-19-31(22,32)7/h21-22,25-26,35H,9-20H2,1-8H3,(H,33,34)/t21-,22-,25+,26+,30-,31-,32+/m1/s1

Standard InChI Key:  GVKJVYFJXDOWGD-GJDKCOEZSA-N

Associated Targets(Human)

Alpha-crystallin B chain 132 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 502.78Molecular Weight (Monoisotopic): 502.4022AlogP: 7.78#Rotatable Bonds: 8
Polar Surface Area: 66.76Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.21CX Basic pKa: CX LogP: 6.76CX LogD: 3.73
Aromatic Rings: 0Heavy Atoms: 36QED Weighted: 0.33Np Likeness Score: 2.66

References

1. Yang X, Chen XJ, Yang Z, Xi YB, Wang L, Wu Y, Yan YB, Rao Y..  (2018)  Synthesis, Evaluation, and Structure-Activity Relationship Study of Lanosterol Derivatives To Reverse Mutant-Crystallin-Induced Protein Aggregation.,  61  (19): [PMID:30153006] [10.1021/acs.jmedchem.8b00705]

Source